Tuesday, March 31, 2009

Osteologix Prevails in European Patent Opposition for Osteoporosis Drug

Mar 31, 2009 - Osteologix, Inc. today announced that the European Patent Office (EPO) has upheld the validity of the company's European Patent No. EP 1,534,305 B9, "Treating Cartilage and Bone Conditions with Water Soluble Strontium Salts".

The details can be read here.

No comments: